Results 161 to 170 of about 105,360 (214)

Budget impact analysis of including biosimilar adalimumab on formulary: A US payer perspective. [PDF]

J Manag Care Spec Pharm
McGill S.
europepmc   +1 more source

Budget impact analysis of cabergoline for medical treatment of Cushing's disease in Brazil. [PDF]

Arch Endocrinol Metab
Silva LFO, Galendi JSC, Martins MRA, Nogueira VDSN.   +3 more
europepmc   +1 more source

Wisely frugal: ensuring sustainable funding for novel cancer therapeutics through a budget impact analysis in resource-limited settings. [PDF]

Ecancermedicalscience
Joseph N, Peiris V, Bamunuarachchi V, Abeysinghe P, Jeyakumaran N, Jayathilake D, Perera K, Fernandopulle R, Gunasekera S.   +8 more
europepmc   +1 more source

A budget impact analysis of gene therapy for sickle cell disease: an updated analysis. [PDF]

Blood Adv
DeMartino PC, Haag MB, Caughey AB, Roth JA.   +3 more
europepmc   +1 more source

Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain. [PDF]

J Clin Med
Moya Torrecilla F, Álvarez-Corral G, Gutiérrez Pérez E, Morell-Garcia D, Ortega Pérez J, Rodríguez BM, Sánchez Martín L, Temboury Ruiz F.   +7 more
europepmc   +1 more source